Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

15.65 

0.37 2.4%

as of Feb 15 '19

52 Week Range:

12.32 56.05


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity; Juliet, a laser system for vaginal health; and Secret RF, a fractional radio frequency microneedling device for skin rejuvenation. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; and CoolGlide, as well as myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Equity (BVPS) 8.58
8.77
7.51
7.00
6.55
6.38
6.15
5.59
3.80
3.81
4.54
growth rate 2.2% -14.4% -6.8% -6.4% -2.6% -3.6% -9.1% -32.0% 0.3% 19.2%
Earnings BIT 13.76
-3.66
-8.77
-10.52
-9.82
-6.30
-5.30
-9.97
-4.52
2.40
7.08
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 195.2%
Avg.PE 21.28
-48.80
-6.00
-11.20
-11.20
-17.10
-10.83
-10.83
-10.83
108.42
24.63
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -77.3%
ROA 7.71
-2.08
-13.66
-9.02
-9.02
-5.84
-4.29
-9.75
-4.76
3.04
29.54
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 871.7%
ROE 9.59
-2.59
-16.60
-10.72
-10.76
-7.18
-5.42
-12.88
-6.80
4.64
47.64
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 926.7%
ROIC 6.66
-2.59
-16.60
-10.72
-11.38
-7.71
-5.90
-12.88
-7.28
4.08
47.64
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 1,067.7%
Cur. Ratio 6.11
6.88
6.89
7.88
6.23
5.87
5.54
4.56
3.02
3.09
2.04
growth rate 12.6% 0.2% 14.4% -20.9% -5.8% -5.6% -17.7% -33.8% 2.3% -34.0%
Quick Ratio 5.28
5.95
6.32
7.18
5.52
5.18
4.98
4.01
2.46
2.49
1.31
growth rate 12.7% 6.2% 13.6% -23.1% -6.2% -3.9% -19.5% -38.7% 1.2% -47.4%
Leverage 1.27
1.23
1.20
1.17
1.22
1.24
1.29
1.35
1.55
1.51
1.71
growth rate -3.2% -2.4% -2.5% 4.3% 1.6% 4.0% 4.7% 14.8% -2.6% 13.3%
Balance Sheet Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Acct.Receivable 5.80
3.30
4.20
5.25
8.80
9.70
11.14
11.67
16.55
20.78
growth rate -43.1% 27.3% 25.0% 67.7% 10.2% 14.8% 4.8% 41.8% 25.6%
Acct.Payable 11.84
2.10
1.80
3.08
1.96
2.60
7.00
growth rate -82.3% -14.3% 71.3% -36.5% 32.6% 169.5%
Cur.Assets 118.90
112.30
103.50
106.10
107.00
103.30
104.89
73.83
87.85
88.37
growth rate -5.6% -7.8% 2.5% 0.9% -3.5% 1.5% -29.6% 19.0% 0.6%
Total Assets 137.50
121.40
111.80
111.35
112.80
108.70
108.91
77.52
91.85
111.24
growth rate -11.7% -7.9% -0.4% 1.3% -3.6% 0.2% -28.8% 18.5% 21.1%
Cash 36.50
22.80
12.50
14.02
23.50
16.20
9.80
10.87
13.78
14.18
growth rate -37.5% -45.2% 12.2% 67.6% -31.1% -39.5% 10.9% 26.8% 3.0%
Inventory 9.90
6.40
6.40
10.73
11.10
9.00
10.99
12.08
14.98
28.78
growth rate -35.4% 0.0% 67.6% 3.5% -18.9% 22.1% 9.9% 24.0% 92.2%
Cur.Liabilities 17.30
16.30
13.10
17.02
18.20
18.60
22.99
24.43
28.39
43.31
growth rate -5.8% -19.6% 29.9% 6.9% 2.2% 23.6% 6.3% 16.2% 52.6%
Liabilities 25.40
20.50
16.40
19.79
22.00
24.40
28.41
27.48
30.84
46.35
growth rate -19.3% -20.0% 20.7% 11.2% 10.9% 16.4% -3.2% 12.2% 50.3%
LT Debt 0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.93
0.58
0.58
0.46
growth rate -36.9% -0.3% -21.0%
Equity 109.35
112.10
100.90
95.40
91.57
90.80
84.30
80.51
50.03
61.01
64.89
growth rate 2.5% -10.0% -5.5% -4.0% -0.8% -7.2% -4.5% -37.9% 21.9% 6.4%
Common Shares 14.00
13.00
13.00
14.00
14.00
14.00
14.00
14.00
14.00
14.00
15.00
growth rate -7.1% 0.0% 7.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 7.1%
Cash Flow Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Capital Expenditures 1.00
0.70
0.20
0.30
0.75
0.52
0.52
0.73
0.75
0.54
0.86
growth rate -30.0% -71.4% 50.0% 150.3% -31.3% 0.2% 42.0% 1.6% -28.0% 59.2%
Cash Dividends 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA 16.89
4.30
0.04
-8.06
-5.17
-2.30
3.50
-4.29
-1.36
1.99
14.29
growth rate -74.5% -99.1% -100.0% 0.0% 0.0% 100.0% -100.0% 0.0% 100.0% 617.2%
FCF per Share 1.12
0.28
-0.01
-0.62
-0.49
-0.20
0.25
-0.18
-0.41
0.06
0.78
growth rate -75.0% -100.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 100.0% 1,200.0%
Sale Purchase of Stock 1.36
0.00
-10.00
3.76
11.08
10.11
5.44
growth rate -100.0% 100.0% 194.8% -8.7% -46.3%
FCF 16.00
4.00
-0.10
-8.00
-6.00
-3.00
3.00
-5.00
-2.00
1.00
13.00
growth rate -75.0% -100.0% 0.0% 0.0% 0.0% 100.0% -100.0% 0.0% 100.0% 1,200.0%
Income Statement Dec '07 Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17
Sales 101.73
83.40
53.70
53.30
60.29
77.30
74.60
78.14
94.76
118.06
151.49
growth rate -18.0% -35.6% -0.7% 13.1% 28.2% -3.5% 4.7% 21.3% 24.6% 28.3%
Op.Income -3.20
-10.30
-11.10
-10.06
-6.50
-4.70
-9.97
-4.52
2.40
7.08
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 195.2%
IBT -3.70
-8.80
-10.50
-9.82
-6.30
-5.30
-10.39
-4.23
2.72
11.96
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 339.7%
Net Income -2.90
-17.70
-10.50
-10.06
-6.50
-4.70
-10.61
-4.44
2.58
29.99
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 1,063.9%
EPS 0.74
-0.22
-1.33
-0.78
-0.73
-0.46
-0.33
-0.74
-0.32
0.19
2.04
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 973.7%
Gross Profit 66.72
51.00
31.90
30.20
34.31
43.10
41.90
44.02
54.28
68.14
86.11
growth rate -23.6% -37.5% -5.3% 13.6% 25.6% -2.8% 5.1% 23.3% 25.5% 26.4%
R&D 7.60
6.80
7.00
9.14
8.40
9.20
10.54
10.73
11.23
12.87
growth rate -10.5% 2.9% 30.6% -8.1% 9.5% 14.6% 1.8% 4.7% 14.6%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 2.22
4.54
-4.75
-2.16
-1.00
growth rate 105.0% -100.0% 0.0% 0.0%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 19.60
20.78
19.86
22.12
25.44
growth rate 6.0% -4.4% 11.4% 15.0%
Acct.Payable 5.81
7.00
8.21
10.74
13.32
growth rate 20.6% 17.2% 30.9% 24.0%
Cur.Assets 96.70
88.37
77.41
84.73
87.37
growth rate -8.6% -12.4% 9.5% 3.1%
Total Assets 100.65
111.24
108.13
115.73
118.94
growth rate 10.5% -2.8% 7.0% 2.8%
Cash 14.78
14.18
10.91
18.43
21.87
growth rate -4.1% -23.1% 69.0% 18.6%
Inventory 23.73
28.78
30.98
30.14
31.32
growth rate 21.3% 7.6% -2.7% 3.9%
Cur.Liabilities 36.81
43.31
37.14
42.79
45.16
growth rate 17.7% -14.3% 15.2% 5.6%
Liabilities 39.44
46.35
40.27
46.36
48.54
growth rate 17.5% -13.1% 15.1% 4.7%
LT Debt 0.51
0.46
0.58
growth rate -8.9% 26.7%
Equity 61.21
64.89
67.86
69.37
70.40
growth rate 6.0% 4.6% 2.2% 1.5%
Common Shares 0.01
0.01
0.01
0.01
0.01
growth rate -7.1% 7.7% 0.0% 0.0%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 0.23
0.41
0.10
0.48
0.63
growth rate 76.8% -74.8% 358.7% 32.7%
Cash Dividends
growth rate
Cash From OA 3.72
6.68
-10.05
3.54
-1.62
growth rate 79.9% -100.0% 100.0% -100.0%
Sale Purchase of Stock 0.70
0.87
0.63
2.41
growth rate 25.0% -27.2% 279.9%
FCF 3.48
6.27
-10.15
3.07
-2.25
growth rate 80.1% -100.0% 100.0% -100.0%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 38.17
47.63
34.13
42.55
40.57
growth rate 24.8% -28.4% 24.7% -4.7%
Op.Income 2.22
4.54
-4.75
-2.16
-1.00
growth rate 105.0% -100.0% 0.0% 0.0%
IBT 6.41
4.68
-4.65
-2.28
-1.05
growth rate -27.0% -100.0% 0.0% 0.0%
Net Income 6.19
22.88
-2.03
-1.57
-0.87
growth rate 269.8% -100.0% 0.0% 0.0%
EPS
growth rate
Gross Profit 22.21
27.33
17.33
22.38
21.89
growth rate 23.1% -36.6% 29.1% -2.2%
R&D 3.47
3.48
3.56
4.10
3.24
growth rate 0.4% 2.2% 15.2% -20.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (54.40)

YOY Growth Grade:

F (8.79)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 11.85 11.85 37.26
EPS / Growth 0.0% 1.32 22.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 0.0% 0.5% 0.5%
Future PE 0.00 6.43 6.43
Future EPS 1.32 1.39 1.39
Value Price
MOS %
0.00
-100.0%
2.21
-85.9%
2.21
-85.9%
MOS Price 0.00 1.10 1.10
IRT 11.85 11.48 11.48

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.